- Home
- EHTH vs AQST Comparison
EHTH vs AQST Comparison
Compare EHTH & AQST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EHTH
- AQST
- Stock Information
- Founded
- EHTH 1997
- AQST 2004
- Country
- EHTH United States
- AQST United States
- Employees
- EHTH N/A
- AQST N/A
- Industry
- EHTH Specialty Insurers
- AQST Biotechnology: Pharmaceutical Preparations
- Sector
- EHTH Finance
- AQST Health Care
- Exchange
- EHTH Nasdaq
- AQST Nasdaq
- Market Cap
- EHTH 292.7M
- AQST 274.4M
- IPO Year
- EHTH 2006
- AQST 2018
- Fundamental
- Price
- EHTH $7.17
- AQST $3.21
- Analyst Decision
- EHTH Hold
- AQST Strong Buy
- Analyst Count
- EHTH 5
- AQST 7
- Target Price
- EHTH $7.70
- AQST $10.57
- AVG Volume (30 Days)
- EHTH 286.1K
- AQST 1.3M
- Earning Date
- EHTH 05-06-2025
- AQST 03-05-2025
- Dividend Yield
- EHTH N/A
- AQST N/A
- EPS Growth
- EHTH N/A
- AQST N/A
- EPS
- EHTH N/A
- AQST N/A
- Revenue
- EHTH $532,409,999.00
- AQST $57,561,000.00
- Revenue This Year
- EHTH $1.50
- AQST N/A
- Revenue Next Year
- EHTH $8.74
- AQST $35.72
- P/E Ratio
- EHTH N/A
- AQST N/A
- Revenue Growth
- EHTH 17.56
- AQST 13.80
- 52 Week Low
- EHTH $3.58
- AQST $2.24
- 52 Week High
- EHTH $11.36
- AQST $5.80
- Technical
- Relative Strength Index (RSI)
- EHTH 32.55
- AQST 59.22
- Support Level
- EHTH $7.21
- AQST $2.71
- Resistance Level
- EHTH $7.63
- AQST $2.91
- Average True Range (ATR)
- EHTH 0.45
- AQST 0.21
- MACD
- EHTH -0.09
- AQST 0.07
- Stochastic Oscillator
- EHTH 2.37
- AQST 95.60
About EHTH eHealth Inc.
eHealth Inc is a company involved in private health insurance marketplace with a technology and service platform that provides consumer engagement, education and health insurance enrollment solutions. The company operates its business in two segments: Medicare and Employer and Individual. It derives maximum revenue from Medicare Segment. All of the company's revenue is from the United States. It also has a presence in China.
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Sympazan Oral Film, Suboxone Sublingual Film, Exservan Oral Film, and Zuplenz. The product pipeline includes Libervant Buccal Film, AQST-108, and AQST-305. The majority of its revenue comes from the United States.